Literature DB >> 17957227

Sex-specific interaction between APOE and APOA5 variants and determination of plasma lipid levels.

Jaroslav A Hubacek1, Vera Lánská, Zdena Skodová, Vera Adámková, Rudolf Poledne.   

Abstract

The APOA5 and APOE genes play an important role in determination of plasma levels of triglycerides (TG) and total cholesterol (TC). We have analyzed APOA5 (T-1131>C and Ser19>Trp) and APOE (e2/e3/e4) variants in 2500 representatively selected Caucasians (1168 men, 1332 women). In female subjects (but not in male) an association between APOE polymorphism and TC was observed on the background of the common APOA5 haplotype (TT-1131/SerSer19) - APOE2 carriers have the lowest (5.12 (1.15) mmol/l) and the APOE4 carriers have the highest (6.05 (1.06) mmol/l) levels of plasma TC (P<0.001). If at least one APOA5 C-1131 or Trp19 allele was present, APOE exhibits no significant effect on plasma TC. APOA5 did not affect plasma TG levels, if APOE4 allele was present. In the presence of APOE2 or APOE3, carriers of the APOA5 alleles, C-1131 and/or Trp19, have higher TG levels (1.64 (1.05) mmol/l) than others (1.37 (0.75) mmol/l) (P<0.01). In male subjects, the same, but non-significant trend was observed. In female subjects, we have detected an interaction between APOE and APOA5 variants and plasma lipid levels.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17957227     DOI: 10.1038/sj.ejhg.5201941

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  8 in total

Review 1.  Apolipoprotein A5 fifteen years anniversary: Lessons from genetic epidemiology.

Authors:  Jaroslav A Hubacek
Journal:  Gene       Date:  2016-08-02       Impact factor: 3.688

2.  APOE -491 T allele may reduce the risk of atherosclerotic lesions among middle-aged women.

Authors:  Virginia G Bañares; Ariel Bardach; Graciela Peterson; Marcelo J Tavella; Laura E Schreier
Journal:  Mol Cell Biochem       Date:  2011-11-22       Impact factor: 3.396

3.  Apolipoprotein A5-1131T>C polymorphism, but not APOE genotypes, increases susceptibility for dyslipidemia in children and adolescents.

Authors:  D D V Brito; A P Fernandes; K B Gomes; F F Coelho; N G Cruz; A P Sabino; J E Cardoso; P P Figueiredo-Filho; R Diamante; C R Norton; M O Sousa
Journal:  Mol Biol Rep       Date:  2010-12-04       Impact factor: 2.316

4.  Additive effects of LPL, APOA5 and APOE variant combinations on triglyceride levels and hypertriglyceridemia: results of the ICARIA genetic sub-study.

Authors:  María-José Ariza; Miguel-Angel Sánchez-Chaparro; Francisco-Javier Barón; Ana-María Hornos; Eva Calvo-Bonacho; José Rioja; Pedro Valdivielso; José-Antonio Gelpi; Pedro González-Santos
Journal:  BMC Med Genet       Date:  2010-04-29       Impact factor: 2.103

5.  Overexpression of apolipoprotein A5 in mice is not protective against body weight gain and aberrant glucose homeostasis.

Authors:  Nathalie Pamir; Timothy S McMillen; Yu-I Li; Ching-Mei Lai; Howard Wong; Renée C LeBoeuf
Journal:  Metabolism       Date:  2009-04       Impact factor: 8.694

6.  Exogenous visual orienting is associated with specific neurotransmitter genetic markers: a population-based genetic association study.

Authors:  Rebecca A Lundwall; Dong-Chuan Guo; James L Dannemiller
Journal:  PLoS One       Date:  2012-02-14       Impact factor: 3.240

7.  Genetic contributions to attentional response time slopes across repeated trials.

Authors:  Rebecca A Lundwall; James L Dannemiller
Journal:  BMC Neurosci       Date:  2015-10-15       Impact factor: 3.288

8.  Influence of APOA5 Locus on the Treatment Efficacy of Three Statins: Evidence From a Randomized Pilot Study in Chinese Subjects.

Authors:  Sha Hua; Chuanxiang Ma; Jun Zhang; Jing Li; Weiwei Wu; Ning Xu; Guanghua Luo; Jianrong Zhao
Journal:  Front Pharmacol       Date:  2018-04-11       Impact factor: 5.810

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.